Quantitative multimodal multiparametric imaging in Alzheimer's disease

Area of Science:

• Neuroscience
• Medical Imaging
• Biomedical Research

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder impacting memory and cognitive functions.
• There is a growing need for early diagnostic tools for AD.
• Neuroimaging plays a crucial role in understanding AD pathophysiology.

Purpose of the Study:

• To provide a preliminary summary of various in vivo neuroimaging techniques for Alzheimer's disease.
• To highlight recent advances in neuroimaging for AD diagnosis and drug development.
• To explore the potential of multimodality and multiparametric neuroimaging in AD research.

Main Methods:

• Review of magnetic resonance (MR) techniques, including functional MRI (fMRI) and diffusion MRI.
• Discussion of Positron Emission Tomography (PET) imaging, including Fluorodeoxyglucose (FDG) PET and amyloid PET.
• Mention of ex vivo modalities such as multiphoton laser scanning microscopy and metal bioimaging.

Main Results:

• MR techniques can visualize anatomy, atrophy, microstructural alterations, and perfusion disturbances in AD.
• Amyloid-beta (Aβ) PET imaging is a key method for early AD diagnosis.
• Multimodality and multiparametric neuroimaging approaches are emerging as powerful tools.

Conclusions:

• Neuroimaging techniques are vital for the early diagnosis and understanding of Alzheimer's disease.
• Advancements in MRI and PET offer significant potential for AD research and clinical applications.
• Future developments in neuroimaging are expected to yield substantial scientific and medical benefits for AD.